查看所有供应商和价格请点击:
1952272-74-0生产厂家
1952272-74-0价格
化源商城直购
[1]. Daniel Vt Catenacci, et al. Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design. Future Oncol. 2019 Jun;15(18):2073-2082.